MECP2 and breast carcinoma: Only one study concentrated on the expression levels of MBD2 and MeCP2 in human breast cancer, indicating a loss of MBD2 expression in breast cancer specimens, but no alteration of the expression level of MeCP2 (Billard et al, 2002).